Focal cortical dysplasia: an update on diagnosis and treatment

References

• Barkovich AJ, Kuzniecky RI, Jackson GD, et al. A developmental and genetic classification for malformations of cortical development. Neurology. 2005;65(12):1873–1887.
   PubMed Web of Science ®Google Scholar
• Blumcke I, Spreafico R, Haaker G, et al., Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 377(17): 1648–1656. 2017. .
   PubMed Web of Science ®Google Scholar
• Lamberink HJ, Otte WM, Blümcke I, et al. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol. 2020;19(9):748–757.
   PubMed Web of Science ®Google Scholar
• Taylor DC, Falconer MA, Bruton CJ, et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry. 1971;34(4):369–387.
   PubMed Web of Science ®Google Scholar
• Fauser S, Schulze-Bonhage A, Honegger J, et al. Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain. 2004;127(11):2406–2418.
   PubMedGoogle Scholar
• Guerrini R, Duchowny M, Jayakar P, et al. Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015;56(11):1669–1686.
   PubMed Web of Science ®Google Scholar
• Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2011;52(1):158–174.
   PubMed Web of Science ®Google Scholar
• Najm IM, Sarnat HBBI. The international consensus classification of focal cortical dysplasia – a critical update 2018. Neuropathol Appl Neurobiol. 2018;44(1):18–31.
   PubMed Web of Science ®Google Scholar
• Harvey A, Mandelstam S, Maixner W, et al. The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia. Neurology. 2015;84(20):2021–2028.
   PubMed Web of Science ®Google Scholar
• Chassoux F, Landré E, Mellerio C, et al. Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia. 2012;53(2):349–358.
   PubMed Web of Science ®Google Scholar
• Najm IM, Tassi L, Sarnat HB, et al. Epilepsies associated with Focal Cortical Dysplasias (FCDs). Acta Neuropathol. 2014;128(1):5–19.
   PubMed Web of Science ®Google Scholar
• Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 2002;125(8):1719–1732.
   PubMedGoogle Scholar
• Krsek P, Pieper T, Karlmeier A, et al. Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia. 2009;50(1):125–137.
   PubMed Web of Science ®Google Scholar
• Mellerio C, Labeyrie MA, Chassoux F, et al. 3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia. 2014;55(1):117–122.
   PubMed Web of Science ®Google Scholar
• Bartolini E, Cosottini M, Costagli M, et al. Ultra-high-field targeted imaging of focal cortical dysplasia: the intracortical black line sign in type IIB. Am J Neuroradiol. 2019;40(12):2137–2142.
   PubMed Web of Science ®Google Scholar
• Blümcke I, Thom M, Aronica E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia. 2013;54(7):1315–1329.
   PubMed Web of Science ®Google Scholar
• Wirrell EC, Shellhaas RA, Joshi C, et al. How should children with west syndrome be efficiently and accurately investigated? Results from the national infantile spasms consortium. Epilepsia. 2015;56(4):617–625.
   PubMed Web of Science ®Google Scholar
• Harvey AS, Berkovic SF, Wrennall JAHI. Temporal lobe epilepsy in childhood: Review article. Neurology. 2006;12:26–31.
   Google Scholar
• Vecchi M, Barba C, De Carlo D, et al. Symptomatic and presumed symptomatic focal epilepsies in childhood: An observational, prospective multicentre study. Epilepsia. 2016;57(11):1808–1816.
   PubMed Web of Science ®Google Scholar
• Bast T, Ramantani G, Ramantani G, et al. Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults. Acta Neurol Scand. 2006;113(2):72–81.
   PubMed Web of Science ®Google Scholar
• Wiwattanadittakul N, Suwannachote S, You X, et al. Spatiotemporal distribution and age of seizure onset in a pediatric epilepsy surgery cohort with cortical dysplasia. Epilepsy Res. 2021;172:106598.
   PubMed Web of Science ®Google Scholar
• Fauser S, Huppertz HJ, Bast T, et al. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain. 2006;129(7):1907–1916.
   PubMedGoogle Scholar
• Desbiens R, Berkovic SF, Dubeau F, et al. Life-threatening focal status epilepticus due to occult cortical dysplasia. Arch Neurol. 1993;50(7):695–700.
   PubMedGoogle Scholar
• Ferrer I, Pineda M, Tallada M, et al. Abnormal local-circuit neurons in epilepsia partialis continua associated with focal cortical dysplasia. Acta Neuropathol. 1992;83(6):647–652.
   PubMed Web of Science ®Google Scholar
• Barba C, Mai R, Grisotto L, et al. Unilobar surgery for symptomatic epileptic spasms. Ann Clin Transl Neurol. 2016;19:36–45.
   Google Scholar
• Kwon HE, Eom S, Kang HC, et al. Surgical treatment of pediatric focal cortical dysplasia. Neurology. 2016;87(9):945–951.
   PubMed Web of Science ®Google Scholar
• Serino D, Freri E, Ragona F, et al. Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year. Epilepsy Res. 2015;109:203–209.
   PubMed Web of Science ®Google Scholar
• Lawson JA, Birchansky S, Pacheco E, et al. Distinct clinicopathologic subtypes of cortical dysplasia of Taylor. Neurology. 2005;64(1):55–56.
   PubMed Web of Science ®Google Scholar
• Hildebrandt M, Pieper T, Winkler P, et al. Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol. 2005;110(1):1–11.
   PubMed Web of Science ®Google Scholar
• Kimura N, Takahashi Y, Shigematsu H, et al. Risk factors of cognitive impairment in pediatric epilepsy patients with focal cortical dysplasia. Brain Dev. 2019;41(1):77–84.
   PubMed Web of Science ®Google Scholar
• Wang TS, Liu QZ, Liu M, et al. Clinical features and surgical outcomes in young children with focal cortical dysplasia type II. CNS Neurosci Ther. 2020;26(2):270–277.
   PubMed Web of Science ®Google Scholar
• Francione S, Vigliano P, Tassi L, et al. Surgery for drug resistant partial epilepsy in children with focal cortical dysplasia: anatomical–clinical correlations and neurophysiological data in 10 patients. J Neurol Neurosurgery, and Psychiatry. 2003;74(11):1493–1501.
   PubMed Web of Science ®Google Scholar
• Chassoux F, Devaux B, Landré E, et al. Stereoelectroencephalography in focal cortical dysplasia: a 3D approach to delineating the dysplastic cortex. Brain. 2000;123(8):1733–1751.
   PubMedGoogle Scholar
• Ho CSH, Dubeau F, Séguin R, et al. Prevalence of neuropsychiatric symptoms associated with malformations of cortical development. Epilepsy Behav. 2019;92:306–310.
   PubMed Web of Science ®Google Scholar
• Barkovich AJ, Guerrini R, Kuzniecky RI, et al. A developmental and genetic classification for malformations of cortical development: update 2012. Brain. 2012;135:1348–1369.
   PubMed Web of Science ®Google Scholar
• Marín-Padilla M. Developmental neuropathology and impact of perinatal brain damage. III: Gray matter lesions of the neocortex. J Neuropathol Exp Neurol. 1999;58(5):407–429.
   PubMed Web of Science ®Google Scholar
• Krsek P, Jahodova A, Maton B, et al. Low-grade focal cortical dysplasia is associated with prenatal and perinatal brain injury. Epilepsia. 2010;51(12):2440–2448.
   PubMed Web of Science ®Google Scholar
• Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet. 2012;44(8):941–945.
   PubMed Web of Science ®Google Scholar
• Poduri A, Evrony GD, Cai X, et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron. 2012;74(1):41–48.
   PubMed Web of Science ®Google Scholar
• Rivière JB, Mirzaa GM, O’Roak BJ, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012;44(8):934–940.
   PubMed Web of Science ®Google Scholar
• Baldassari S, Ribierre T, Marsan E, et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol. 2019;138(6):885–900.
   PubMed Web of Science ®Google Scholar
• Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84(2):275–291.
   PubMed Web of Science ®Google Scholar
• D’Gama AM, Geng Y, Couto JA, et al. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol. 2015;77(4):720–725.
   PubMed Web of Science ®Google Scholar
• Sim JC, Scerri T, Fanjul-Fernández M, et al. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Ann Neurol. 2016;79(1):132–137.
   PubMed Web of Science ®Google Scholar
• Mirzaa GM, Campbell CD, Solovieff N, et al. Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol. 2016;73(7):836–845.
   PubMed Web of Science ®Google Scholar
• Mirzaa GM, Conti V, Timms AE, et al. Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study. Lancet Neurol. 2015;14(12):1182–1195.
   PubMed Web of Science ®Google Scholar
• Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 2014;13(7):710–726.
   PubMed Web of Science ®Google Scholar
• Lee WS, Stephenson SEM, Stephenson SEM, et al. Genetic characterization identifies bottom-of-sulcus dysplasia as an mTORopathy. Neurology. 2020;95(18):e2542–e2551.
   PubMed Web of Science ®Google Scholar
• Guerrini R, Cavallin M, Pippucci T, et al. Is focal cortical dysplasia/epilepsy caused by somatic MTOR mutations always a unilateral disorder? Neurol Genet. 2021;7(1):e540.
   PubMed Web of Science ®Google Scholar
• Baldassari S, Picard F, Verbeek NE, et al. The landscape of epilepsy-related GATOR1 variants. Genet Med. 2019;21(2):398–408.
   PubMed Web of Science ®Google Scholar
• Ribierre T, Deleuze C, Bacq A, et al. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J Clin Invest. 2018;128(6):2452–2458.
   PubMed Web of Science ®Google Scholar
• Lee WS, Stephenson SEM, Howell KB, et al. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA. Ann Clin Transl Neurol. 2019;6(7):1338–1344.
   PubMed Web of Science ®Google Scholar
• Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820–823.
   PubMed Web of Science ®Google Scholar
• Baulac S, Ishida S, Marsan E, et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC 5 mutations. Ann Neurol. 2015;77(4):675–683.
   PubMed Web of Science ®Google Scholar
• Pelorosso C, Watrin F, Conti V, et al. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy. Hum Mol Genet. 2019;28(22):3755–3765.
   PubMed Web of Science ®Google Scholar
• Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med. 2006;354(13):1370–1377.
   PubMed Web of Science ®Google Scholar
• Barba C, Parrini E, Coras R, et al. Co-occurring malformations of cortical development and SCN1A gene mutations. Epilepsia. 2014;55(7):1009–1019.
   PubMed Web of Science ®Google Scholar
• Skjei KL, Church EW, Harding BN, et al. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. J Neurosurg Pediatr. 2015;16(6):668–674.
   PubMed Web of Science ®Google Scholar
• Weckhuysen S, Holmgren P, Hendrickx R, et al. Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers. Epilepsia. 2013;54(5):e74–80.
   PubMed Web of Science ®Google Scholar
• Kurian M, Korff CM, Ranza E, et al. Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: case report. Dev Med Child Neurol. 2018;60(1):100–105.
   PubMed Web of Science ®Google Scholar
• Klein KM, Pendziwiat M, Cohen R, et al. Autosomal dominant epilepsy with auditory features: a new LGI1 family including a phenocopy with cortical dysplasia. J Neurol. 2016;263(1):11–16.
   PubMed Web of Science ®Google Scholar
• Winawer MR, Griffin NG, Samanamud J, et al. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol. 2018;83(6):1133–1146.
   PubMed Web of Science ®Google Scholar
• Sim NS, Seo Y, Lim JS, et al. Brain somatic mutations in SLC35A2 cause intractable epilepsy with aberrant N-glycosylation. Neurol Genet. 2018;4(6):e294.
   PubMed Web of Science ®Google Scholar
• Miller KE, Koboldt DC, Schieffer KM, et al. Somatic SLC35A2 mosaicism correlates with clinical findings in epilepsy brain tissue. Neurol Genet. 2020;6(4):e460.
   PubMed Web of Science ®Google Scholar
• Bonduelle T, Hartlieb T, Baldassari S, et al. Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). Acta Neuropathol Commun. 2021;9(1):1–13.
   PubMed Web of Science ®Google Scholar
• Kobow K, Ziemann M, Kaipananickal H, et al. Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia. Epilepsia. 2019;60(6):1091–1103.
   PubMed Web of Science ®Google Scholar
• Boonyapisit K, Najm I, Klem G, et al. Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic-histopathologic correlations. Epilepsia. 2003;44(1):69–76.
   PubMed Web of Science ®Google Scholar
• Dubeau F, Palmini A, Fish D, et al. The significance of electrocorticographic findings in focal cortical dysplasia: a review of their clinical, electrophysiological and neurochemical characteristics. Electroencephalogr Clin Neurophysiol Suppl. 1998;48:77–96.
   PubMedGoogle Scholar
• Panzica F, Varotto G, Rotondi F, et al. Identification of the epileptogenic zone from stereo-EEG signals: a connectivity-graph theory approach. Front Neurol. 2013;4:175.
   PubMed Web of Science ®Google Scholar
• Di Giacomo R, Uribe-San-Martin R, Mai R, et al. Stereo-EEG ictal/interictal patterns and underlying pathologies. Seizure. 2019;72:54–60.
   PubMed Web of Science ®Google Scholar
• Lagarde S, Scholly J, Popa I, et al. Can histologically normal epileptogenic zone share common electrophysiological phenotypes with focal cortical dysplasia? SEEG-based study in MRI-negative epileptic patients. J Neurol. 2019;266(8):1907–1918.
   PubMed Web of Science ®Google Scholar
• Bartolomei F, Lagarde S, Wendling F, et al. Defining epileptogenic networks: contribution of SEEG and signal analysis. Epilepsia. 2017;58(7):1131–1147.
   PubMed Web of Science ®Google Scholar
• Aubert S, Wendling F, Regis J, et al. Local and remote epileptogenicity in focal cortical dysplasias and neurodevelopmental tumours. Brain. 2009;132(11):3072–3086.
   PubMedGoogle Scholar
• Frauscher B, Bartolomei F, Kobayashi K, et al. High-frequency oscillations: the state of clinical research. Epilepsia. 2017;58(8):1316–1329.
   PubMed Web of Science ®Google Scholar
• Jacobs J, Levan P, Châtillon C-E, et al. High frequency oscillations in intracranial EEGs mark epileptogenicity rather than lesion type. Brain. 2009;132(4):1022–1037.
   PubMedGoogle Scholar
• Jacobs J, LeVan P, Chander R, et al. Interictal high-frequency oscillations (80–500 Hz) are an indicator of seizure onset areas independent of spikes in the human epileptic brain. Epilepsia. 2008;49(11):1893–1907.
   PubMed Web of Science ®Google Scholar
• Ferrari-Marinho T, Perucca P, Mok K, et al. Pathologic substrates of focal epilepsy influence the generation of high-frequency oscillations. Epilepsia. 2015;56(4):592–598.
   PubMed Web of Science ®Google Scholar
• Kerber K, LeVan P, Dümpelmann M, et al. High frequency oscillations mirror disease activity in patients with focal cortical dysplasia. Epilepsia. 2013;54(8):1428–1436.
   PubMed Web of Science ®Google Scholar
• Stefan H, Schneider S, Abraham-Fuchs K, et al. Magnetic source localization in focal epilepsy. Multichannel magnetoencephalography correlated with magnetic resonance brain imaging. Brain. 1990;113(Pt 5):1347–1359.
   PubMedGoogle Scholar
• Ishibashi H, Simos PG, Wheless JW, et al. Localization of ictal and interictal bursting epileptogenic activity in focal cortical dysplasia: agreement of magnetoencephalography and electrocorticography. Neurol Res. 2002;24(6):525–530.
   PubMed Web of Science ®Google Scholar
• Bast T, Oezkan O, Rona S, et al. EEG and MEG source analysis of single and averaged interictal spikes reveals intrinsic epileptogenicity in focal cortical dysplasia. Epilepsia. 2004;45(6):621–631.
   PubMed Web of Science ®Google Scholar
• Bouet R, Mauguière F, Daligault S, et al. The relationship between morphological lesion, magnetic source imaging, and intracranial stereo-electroencephalography in focal cortical dysplasia. NeuroImage Clin. 2017;15:71–79.
   PubMed Web of Science ®Google Scholar
• Mu J, Rampp S, Carrette E, et al. Clinical relevance of source location in frontal lobe epilepsy and prediction of postoperative long-term outcome. Seizure. 2014;23(7):553–559.
   PubMed Web of Science ®Google Scholar
• Shirozu H, Hashizume A, Masuda H, et al. Surgical strategy for focal cortical dysplasia based on the analysis of the spike onset and peak zones on magnetoencephalography. J Neurosurg. 2019;4:1–13.
   Google Scholar
• Alhilani M, Tamilia E, Ricci L, et al. Ictal and interictal source imaging on intracranial EEG predicts epilepsy surgery outcome in children with focal cortical dysplasia. Clin Neurophysiol. 2020;131(3):734–743.
   PubMed Web of Science ®Google Scholar
• Van Mierlo P, Vorderwülbecke BJ, Staljanssens W, et al. Ictal EEG source localization in focal epilepsy: review and future perspectives. Clin Neurophysiol. 2020;131(11):2600–2616.
   PubMed Web of Science ®Google Scholar
• Federico P, Archer JS, Abbott DFJG. Cortical/subcortical BOLD changes associated with epileptic discharges: an EEG-fMRI study at 3 T. Neurology. 2005;64(7):1125–1130.
   PubMed Web of Science ®Google Scholar
• Pittau F, Ferri L, Fahoum F, et al. Contributions of EEG-fMRI to Assessing the Epileptogenicity of Focal Cortical Dysplasia. Front Comput Neurosci. 2017;11:8.
   PubMed Web of Science ®Google Scholar
• Thornton R, Vulliemoz S, Rodionov R, et al. Epileptic networks in focal cortical dysplasia revealed using electroencephalography-functional magnetic resonance imaging. Ann Neurol. 2011;70(5):822–837.
   PubMed Web of Science ®Google Scholar
• Abdijadid S, Mathern GW, Levine MS, et al. Basic mechanisms of epileptogenesis in pediatric cortical dysplasia. CNS Neurosci Ther. 2015;21(2):92–103.
   PubMed Web of Science ®Google Scholar
• André VM, Flores-Hernández J, Cepeda C, et al. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex. 2004;14(6):634–646.
   PubMed Web of Science ®Google Scholar
• Buccoliero AM, Barba C, Giordano F, et al. Expression of glutamine synthetase in balloon cells: a basis of their antiepileptic role? Clin Neuropathol. 2015;34(2):34.
   PubMed Web of Science ®Google Scholar
• Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008;7(6):525–537.
   PubMed Web of Science ®Google Scholar
• Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol. 2014;13(11):1114–1126.
   PubMed Web of Science ®Google Scholar
• Bernasconi A, Bernasconi N, Bernhardt BC, et al. Advances in MRI for “cryptogenic” epilepsies. Nat Rev Neurol. 2011;7(2):99–108.
   PubMed Web of Science ®Google Scholar
• Winston GP, Micallef C, Kendell BE, et al. The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Res. 2013;105(3):349–355.
   PubMed Web of Science ®Google Scholar
• Woermann FG, Vollmar C. Clinical MRI in children and adults with focal epilepsy: a critical review. Epilepsy Behav. 2009;15(1):40–49.
   PubMed Web of Science ®Google Scholar
• Cendes F, Theodore WH, Brinkmann BH, et al. Neuroimaging of epilepsy. Handb Clin Neurol. 2016;136:985–1014.
   PubMedGoogle Scholar
• Opheim G, Van Der Kolk A, Bloch KM, et al. 7T Epilepsy Task Force Consensus Recommendations on the use of 7T in Clinical Practice. Neurology. 2020; Doi:https://doi.org/10.1212/WNL.0000000000011413. .
   Google Scholar
• De Ciantis A, Barba C, Tassi L, et al., 7T MRI in focal epilepsy with unrevealing conventional field strength imaging. Epilepsia. 57(3): 445–454. 2016. .
   PubMed Web of Science ®Google Scholar
• Veersema TJ, Eijsden PV, Ph G, et al. 7 tesla T2*-weighted MRI as a tool to improve detection of focal cortical dysplasia. DoiOrg. 2016;18:315–323.
   Google Scholar
• Colon AJ, Van Osch MJP, Buijs M, et al. Detection superiority of 7 T MRI protocol in patients with epilepsy and suspected focal cortical dysplasia. Acta Neurol Belg. 2016;116(3):259–269.
   PubMed Web of Science ®Google Scholar
• Wang I, Oh S, Blümcke I, et al. Value of 7T MRI and post-processing in patients with nonlesional 3T MRI undergoing epilepsy presurgical evaluation. Epilepsia. 2020;61(11):2509–2520.
   PubMed Web of Science ®Google Scholar
• Bernasconi A, Antel SB, Collins DL, et al. Texture analysis and morphological processing of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal partial epilepsy. Ann Neurol. 2001;49(6):770–775.
   PubMed Web of Science ®Google Scholar
• House PM, Lanz M, Holst B, et al. Comparison of morphometric analysis based on T1- and T2-weighted MRI data for visualization of focal cortical dysplasia. Epilepsy Res. 2013;106(3):403–409.
   PubMed Web of Science ®Google Scholar
• Wagner J, Weber B, Urbach H, et al. Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain. 2011;134(10):2844–2854.
   PubMedGoogle Scholar
• Wang ZI, Jones SE, Jaisani Z, et al. Voxel-based morphometric magnetic resonance imaging (MRI) postprocessing in MRI-negative epilepsies. Ann Neurol. 2015;77(6):1060–1075.
   PubMed Web of Science ®Google Scholar
• Huppertz H-J, Grimm C, Fauser S, et al. Enhanced visualization of blurred gray-white matter junctions in focal cortical dysplasia by voxel-based 3D MRI analysis. Epilepsy Res. 2005;67(1–2):35–50.
   PubMed Web of Science ®Google Scholar
• El Tahry R, Santos SF, Vrielynck P, et al. Additional clinical value of voxel-based morphometric MRI post-processing for MRI-negative epilepsies: a prospective study. Epileptic Disord. 2020;22(2):156–164.
   PubMed Web of Science ®Google Scholar
• Adler S, Wagstyl K, Gunny R, et al. Novel surface features for automated detection of focal cortical dysplasias in paediatric epilepsy. NeuroImage Clin. 2017;14:18–27.
   PubMed Web of Science ®Google Scholar
• Ahmed B, Brodley CE, Blackmon KE, et al. Cortical feature analysis and machine learning improves detection of “MRI-negative” focal cortical dysplasia. Epilepsy Behav. 2015;48:21–28.
   PubMed Web of Science ®Google Scholar
• Jayalakshmi S, Nanda SK, Vooturi S, et al. Focal cortical dysplasia and refractory epilepsy: role of multimodality imaging and outcome of surgery. Am J Neuroradiol. 2019;40(5):892–898.
   PubMed Web of Science ®Google Scholar
• Salamon N, Kung J, Shaw SJ, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71(20):1594–1601.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Togao O, Yamashita K, et al. Diagnostic accuracy for the epileptogenic zone detection in focal epilepsy could be higher in FDG-PET/MRI than in FDG-PET/CT. Eur Radiol. 2020;OCT:15.
   Google Scholar
• Chassoux F, Rodrigo S, Semah F, et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology. 2010;75(24):2168–2175.
   PubMed Web of Science ®Google Scholar
• Lagarde S, Boucekine M, McGonigal A, et al. Relationship between PET metabolism and SEEG epileptogenicity in focal lesional epilepsy. Eur J Nucl Med Mol Imaging. 2020;47(13):3130–3142.
   PubMed Web of Science ®Google Scholar
• Kudr M, Krsek P, Maton B, et al. Predictive factors of ictal SPECT findings in paediatric patients with focal cortical dysplasia. Epileptic Disord. 2013;15(4):383–391.
   PubMed Web of Science ®Google Scholar
• O’Brien TJ, So EL, Cascino GD, et al. Subtraction SPECT coregistered to MRI in focal malformations of cortical development: localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia. 2004;45(4):367–376.
   PubMed Web of Science ®Google Scholar
• Gupta A, Raja S, Kotagal P, et al. Ictal SPECT in children with partial epilepsy due to focal cortical dysplasia. Pediatr Neurol. 2004;31(2):85–95.
   Web of Science ®Google Scholar
• Krsek P, Kudr M, Jahodova A, et al. Localizing value of ictal SPECT is comparable to MRI and EEG in children with focal cortical dysplasia. Epilepsia. 2013;54(2):351–358.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kang HC, Kim DS, et al. Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Epilepsia. 2011;52(4):722–727.
   PubMed Web of Science ®Google Scholar
• Jayakar P, Gaillard WD, Tripathi M, et al. Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Epilepsia. 2014;55(4):507–518.
   PubMed Web of Science ®Google Scholar
• Gaillard WD, Cross JH, Duncan JS, et al. Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters. Epilepsia. 2011;52(9):1750–1756.
   PubMed Web of Science ®Google Scholar
• Nowell M, Rodionov R, Zombori G, et al. A pipeline for 3D multimodality image integration and computer-assisted planning in epilepsy surgery. J Vis Exp. 2016;20:53450.
   Google Scholar
• Palmini A, Andermann F, Olivier A, et al. Neuronal migration disorders: a contribution of modern neuroimaging to the etiologic diagnosis of epilepsy. Can J Neurol Sci. 1991;8(S4):580–587.
   Google Scholar
• Widdess-Walsh P, Kellinghaus C, Jeha L, et al. Bingaman W NImI. Electro-clinical and imaging characteristics of focal cortical dysplasia: correlation with pathological subtypes. Epilepsy Res. 2005;67(1–2):25–33.
   PubMed Web of Science ®Google Scholar
• Aronica E, Becker AJ, Spreafico R. Malformations of cortical development. Brain Pathol. 2012;22(3):380–401.
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Mahadeo T, Bordey A. mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J Neurosci. 2019;39(14):2762–2773.
   PubMed Web of Science ®Google Scholar
• Galanopoulou AS, Gorter JA, Cepeda C. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia. 2012;53(7):1119–1130.
   PubMed Web of Science ®Google Scholar
• Cepeda C, Levinson S, Yazon VW, et al. Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non–mTOR-mediated etiologies. Epilepsia Open. 2018;3(S2):180–190.
   PubMedGoogle Scholar
• Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363(19):1801–1811. .
   PubMed Web of Science ®Google Scholar
• Zeng L-H, Xu L, Gutmann DH, et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008;63(4):444–453.
   PubMed Web of Science ®Google Scholar
• Krueger DA, Wilfong AA, Holland-Bouley K, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol. 2013;74(5):679–687.
   PubMed Web of Science ®Google Scholar
• Krueger DA, Wilfong AA, Mays M, et al. Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology. 2016;87(23):2408–2415.
   PubMed Web of Science ®Google Scholar
• French JA, Lawson JA, Yapici Z, et al., Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 388(10056): 2153–2163. 2016. .
   PubMed Web of Science ®Google Scholar
• Curatolo P, Franz DN, Lawson JA, et al. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. Lancet Child Adolesc Heal. 2018;2(7):495–504. .
   Web of Science ®Google Scholar
• Franz DN, Lawson JA, Yapici Z, et al. Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial. Neurol Clin Pract. 2018;8(5):412–420.
   PubMedGoogle Scholar
• Overwater IE, Rietman AB, Van Eeghen AM, et al. Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives. Ther Clin Risk Manag. 2019;15:951–955.
   PubMed Web of Science ®Google Scholar
• Van Der Poest Clement E, Jansen FE, Braun KPJ, et al. Update on drug management of refractory epilepsy in tuberous sclerosis complex. Pediatr Drugs. 2020;22(1):73–84.
   PubMed Web of Science ®Google Scholar
• Jeong A, Wong M. Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy. Expert Rev Neurother. 2016;16(4):437–447.
   PubMed Web of Science ®Google Scholar
• Lim JS, Kim WI, Hc K, et al., Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med. 21(4): 395–400. 2015. .
   PubMed Web of Science ®Google Scholar
• Cross JH, Jayakar P, Nordli D, et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the subcommission for pediatric epilepsy surgery. Epilepsia. 2006;47(6):952–959. .
   PubMed Web of Science ®Google Scholar
• Sacino MF, Ho CY, Whitehead MT, et al. Repeat surgery for focal cortical dysplasias in children: indications and outcomes. J Neurosurg Pediatr. 2017;19(2):174–181.
   PubMed Web of Science ®Google Scholar
• Stevelink R, Sanders MWCB, Tuinman MP, et al. Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review. Epileptic Disord. 2018;20(2):99–115.
   PubMed Web of Science ®Google Scholar
• Hauptman JS, Mathern GW. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia. 2012;53:98–104.
   PubMed Web of Science ®Google Scholar
• Hoppe C, Helmstaedter C. Laser interstitial thermotherapy (LiTT) in pediatric epilepsy surgery. Seizure. 2020;77:69–75.
   PubMed Web of Science ®Google Scholar
• Bourdillon P, Rheims S, Catenoix H, et al. Malformations of cortical development: new surgical advances. Rev Neurol (Paris). 2019;175(3):183–188.
   PubMed Web of Science ®Google Scholar
• Cobourn K, Fayed I, Keating RFOC. Early outcomes of stereoelectroencephalography followed by MR-guided laser interstitial thermal therapy: a paradigm for minimally invasive epilepsy surgery. Neurosurg Focus. 2018;45(3):E8.
   PubMed Web of Science ®Google Scholar
• Brown MG, Drees C, Nagae LM, et al. Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy. J Neurol Neurosurg Psychiatry. 2018;89(4):425–433.
   PubMed Web of Science ®Google Scholar